Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001190690 | SCV001358258 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-26 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001448367 | SCV001651456 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2022-05-27 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002271599 | SCV002555839 | likely benign | not specified | 2022-06-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001190690 | SCV002738548 | likely benign | Hereditary cancer-predisposing syndrome | 2021-01-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Institute for Biomarker Research, |
RCV001190690 | SCV004228162 | likely benign | Hereditary cancer-predisposing syndrome | 2023-10-17 | criteria provided, single submitter | clinical testing |